Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Logan Kelley-Baker
Observed names:
Kelley-Baker, Logan,
Logan K. Baker,
Logan Kelley Baker,
Logan Kelly-Baker
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
Government of the United States of America
ORCID:
0000-0003-4411-2058
Observed ORCID:
0000-0003-4411-2058
OpenAlex ID:
A5007404000
Detection of Innate Immune Response Modulating Impurities in Therapeutic Proteins
2015
·
Lydia Asrat Haile
, Montserrat Puig
, et al.
·
PLoS ONE
·
72
PDF
Long-term persistence of infectious Zika virus: Inflammation and behavioral sequela in mice
2020
·
Derek D.C. Ireland
, Mohanraj Manangeeswaran
, et al.
·
PLoS Pathogens
·
62
PDF
Cell based assay identifies TLR2 and TLR4 stimulating impurities in Interferon beta
2017
·
Lydia Asrat Haile
, Swamy Kumar Polumuri
, et al.
·
Scientific Reports
·
33
PDF
Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients
2022
·
Seth G. Thacker
, Cheng Her
, et al.
·
Frontiers in Immunology
·
20
PDF
Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
2021
·
Ha-Na Lee
, Ian L. McWilliams
, et al.
·
Emerging Microbes & Infections
·
14
BSL2-compliant lethal mouse model of SARS-CoV-2 and variants of concern to evaluate therapeutics targeting the Spike protein
2022
·
Mohanraj Manangeeswaran
, Derek D.C. Ireland
, et al.
·
Frontiers in Immunology
·
8
Cell-Based Assays to Detect Innate Immune Response Modulating Impurities: Application to Biosimilar Insulin
2024
·
Cheng Her
, Seth Thacker
, et al.
·
The AAPS Journal
·
6
PDF
CpG oligodeoxynucleotides and pan-serotype inhibitors control neurotropic dengue infection in novel immune competent neonatal mouse model
2025
·
Mirian Mendoza
, Derek D.C. Ireland
, et al.
·
Emerging Microbes & Infections
·
4
Ebola virus-induced eye sequelae: a murine model for evaluating glycoprotein-targeting therapeutics
2024
·
Ha-Na Lee
, Biying Xu
, et al.
·
EBioMedicine
·
4
PDF
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
2026
·
Jennifer K. Lee
, Ha-Na Lee
, et al.
·
The AAPS Journal
·
1
PDF
Immunologic and placental responses to the VSV-EBOV vaccine in a pregnant mouse model
2026
·
Aaron P. Lewkowicz
, Yiru Wang
, et al.
·
JCI Insight
Multiplexed Immunophenotyping for Innate Activation Assessment Detects Single-Cell Responses to Immunomodulatory Nucleic Acid Impurities in Therapeutics
2026
·
Joseph A. Balsamo
, Mirian Mendoza
, et al.
·
The AAPS Journal
Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model
2021
·
Lee, Ha-Na
, McWilliams, Ian L.
, et al.
·
Figshare
Show more works
View as search
Works count:
13
Citation count:
224
H-index:
6
I10-index:
5
Year
Topic
Type